Symposium:
035. Current Issues, Conundrums, and Challenges with Respiratory Viruses
Thursday, October 5, 2017: 10:30 AM-12:00 PM
Room: 14AB

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • describe the epidemiology of respiratory adenovirus infections
  • identify adenovirus disease prevention strategies
  • describe the management of antibiotics in the setting of acute respiratory illness caused by viruses,
  • discuss up to date surveillance regarding MERS-CoV and control strategies for emerging human coronavirus infections

Target Audience: Academicians, Clinicians, Epidemiologists, Fellows, Healthcare workers, Hospital administrators, Hospital epidemiologists, Infection preventionists, Infectious diseases pediatricians, Infectious diseases physicians, Investigators, Lab personnel, Medical students and residents, Members-in-training, Pharmacists, Public health practitioners, Researchers, Scientists, Vaccinologists

Tracks: Pediatric ID, Global ID, Epidemiology and Infection Control, Adult ID, Trainee


Moderators:  Inger Damon, MD, PhD, FIDSA, Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases and Susan Gerber, MD, Centers for Disease Control and Prevention

CME Credits: Maximum of 1.50 hours of AMA PRA Category 1 Credit™

ACPE Credits: ACPE 1.5 knowledge-based contact hours of pharmacy CE

ACPE Number: 0221-9999-17-243-L01-P

Disclosures:

I. Damon, None

S. Gerber, None

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.